In early summer of 2021, Loretta Sweet Jemmott, PhD, was unanimously selected to receive the Lazarex Cancer Foundation Disruptor Award for being an individual who has responded with urgency, taking action to combat low minority participation in cancer clinical trials and has disrupted the current status quo by raising awareness about existing problems, putting patients’ interests first and demonstrating a commitment to working on solutions.
STAT — a Boston-based national publication focused on science and health news — has named a Drexel University College of Medicine postdoc one of the “brightest young minds in life science.” Halley Oyer, PhD, was […]
Look inside the abdomen of a patient suffering from PMP — a rare, slow-growing cancer — and you’ll find layers of mucus-producing tumors. Abdominal conditions, such as appendiceal/PMP, peritoneal mesothelioma, colon and ovarian cancers, are […]
When cancer surgeons remove tumors from the body, the difference between success and failure is often just a few cells. Any lingering malignancy could lead to a recurrence of the cancer, so it is vital […]
Asbestos. It isn’t just a word that sends a chill to homeowners renovating old buildings; it’s a naturally occurring mineral in widespread commercial and industrial use that still poses a public health hazard today. It’s […]